Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592552 · ClinicalTrials.gov registry record
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
A clinical trial, sponsored by Sanguine Biosciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT01592552: Completed study, sponsored by Sanguine Biosciences.
NCT01592552 is a clinical trial that has completed, run by Sanguine Biosciences. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592552 has completed, sponsored by Sanguine Biosciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
Primary Outcome
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-03 |
What the finished NCT01592552 record still lists
NCT01592552 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01592552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01592552 about?
NCT01592552 is a clinical study titled "A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery". The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
What is the current status of trial NCT01592552?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01592552?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia